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Abstract
Background: The number of publications on clinical trials is unknown as well as the countries
publishing most trial reports. To try to examine these questions we performed an ecological study.
Methods: We searched the 454,449 records on publications in The Cochrane Central Register of
Controlled Trials (CENTRAL) in The Cochrane Library, Issue 3, 2005 (CD-ROM version) for
possible country of origin. We inspected a random sample of 906 records for information on
country and type of trial.
Results: There was an exponential growth of publications on randomised controlled trials and
controlled clinical trials since 1946, but the growth seems to have seized since 2000. We identified
the possible country of origin of 210,974 publications (46.4%). The USA is leading with about
46,789 publications followed by UK, Germany, Italy, the Netherlands, Canada, and France. Sweden
becomes the leader with 891 publications per million inhabitants during the last 60 years followed
by Denmark (n = 864), New Zealand (n = 791), Finland (n = 781), the Netherlands (n = 570),
Switzerland (n = 547), and Norway (n = 543). In depth assessment of the random sample backed
these findings.
Conclusion: Many records lacked country of origin, even after the additional scrutiny. The
number of publications on clinical trials increased exponentially until the turn of the century. Rather
small, democratic, and wealthy countries take the lead when the number of publications on clinical
trials is calculated based on million inhabitants. If all countries produced the same number of trials
as these countries, this could mean thousands of new effective treatments during the next 60 years.
Background
On the 20th of May 1747, the Scottish naval surgeon James
Lind started his controlled clinical trial of six interven-
tions for scurvy patients [1]. The results were published in
1753 in his Treatise of the Scurvy [1]. Early examples of ran-
domised, placebo-controlled trials date back to the
Nuremberg salt trial from 1835 [2]. Physicians took their
time. The whole idea of randomised controlled trials was
first more widely accepted at the end of the Second World
War [3]. Since then hundred thousands of clinical trials
have been conducted all over the world [4,5], but many
remain unpublished [6,7].
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top 50 biomedical journals during 1995 to 2002, even
after adjusting for population size, gross domestic prod-
uct, and other factors [8]. These results confirm previous
observations on the leading role of USA in clinical cardi-
ology [9], clinical oncology [10], and biomedical research
[11]. None of these studies – or other studies that we have
been able to identify – have examined the production of
randomised controlled trials and controlled clinical trials
per country within all specialities.
The Cochrane Central Register of Controlled Trials (CEN-
TRAL) in The Cochrane Library, being reputed as the most
comprehensive trial register that exists [4,5], represents an
opportunity to get an impression of the development over
time and of the ranking of countries regarding publica-
tions on randomised controlled trials and controlled clin-
ical trials. We aimed to assess the connection between
number of inhabitants per country on one hand and pub-
lications on clinical trials on the other by the performance
of an ecological study.
Methods
We searched The Cochrane Central Register of Controlled
Trials (CENTRAL) in The Cochrane Library Issue 3, 2005
(CD-ROM version) [4,5] to identify the number of publi-
cations on randomised controlled trials or controlled clin-
ical trials per five-year interval and per country. The search
terms were country names alone or a country name com-
bined either with old or present names of the country and
names of big provinces and big cities of each country. This
was done since a separate search field tag with informa-
tion for country of origin does not always exist in CEN-
TRAL. We exported a random sample of 906 records
(every 500 record) into a ProCite database for further
analysis of the information on likely country of origin and
type of trial. We identified country of origin by reading the
record in CENTRAL. For the records without a country
identifier, we searched EMBASE and MEDLINE via Win-
SPIRS, version 5.0, and Web of Science® for country of ori-
gin. We sought the country of origin from the address field
of those references that have one. For those without we
sought country of origin through the town, city, province,
or institution, so we could identify the likely country.
Number of inhabitants per country in 2003 was extracted
from the United Nations Department of Economic and
Social Affairs [12]. We used Microsoft Excel to input data
and produce charts ranking the top 20 countries.
Results
CENTRAL stored a total of 454,449 publications. The
number of publications per five-year period after 1946 is
shown in Figure 1. The number of publications increased
exponentially to 2000. The growth seems to have seized at
the turn of the century. During the last 10 years about
25,000 publications on randomised controlled or con-
trolled clinical trials have been published each year.
We could identify the possible country of origin of
210,974 publications in CENTRAL (46.4%). USA is the
country producing most publications on randomised con-
trolled trials or controlled clinical trials during the last 60
years (n = 46,789; 22.2%), followed by UK (n = 26,401;
12.5%), Germany (n = 11,782, 5.6%), Italy (n = 11,587;
5.5%), the Netherlands (n = 9,233; 4.4%), Canada (n =
9,134; 4.3%), and France (n = 8,666; 4.1%) (Figure 2).
We inspected the contents of the randomly selected 906
records from CENTRAL. Our observations showed that
419 records (46.2%) were tagged as randomised control-
led trials by MEDLINE; 209 records (23.1%) were tagged
as randomised controlled trials by the Cochrane Review
Group that had submitted the record for inclusion in
CENTRAL; and 193 records (21.3%) were controlled clin-
ical trials either tagged by MEDLINE or the Cochrane
Review Group. Accordingly, 821/906 references (90.6%;
95% confidence interval 88.5 to 92.4%) were references
to randomised controlled trials or controlled clinical tri-
als. The majority of the records being clinical trials were
randomised controlled trials (628/821; 76.5%).
Only 368 records out of the 821 records on randomised
controlled trials or controlled clinical trials gave a country
identifier (44.8%, 95% confidence interval 41.4 to
48.3%). Only 29 records out of the 85 records, which did
not refer to a randomised controlled trial or a controlled
clinical trial, gave a country identifier (34.2%; 95% confi-
dence interval 24.2 to 45.2%). We searched EMBASE and
MEDLINE via WinSPIRS, version 5.0, and Web of Science®
to identify the likely country of origin of the remaining
509 references without a country identifier. We were able
to identify a likely country of origin for an additional 163
of 453 references on randomised controlled trials or con-
trolled clinical trials and 14 out of 56 references on
records, which did not seem to deal with a clinical trial.
The distribution of countries between the 368 references
with a country of origin and the 163 references without a
country identifier in CENTRAL was not significantly dif-
ferent (data not shown). Most of the records in CENTRAL
for which we were unable to identify a likely country of
origin were references to meeting abstracts.
We calculated the number of publications on randomised
controlled trials and controlled clinical trials per million
inhabitants in each country during the last 60 years (Fig-
ure 3). Ranked in this way, Sweden (n = 891), Denmark
(n = 864), New Zealand (n = 791), Finland (n = 781), the
Netherlands (n = 570), Switzerland (n = 547), and Nor-
way (n = 543) are the countries having produced the larg-
est number of publications on clinical trials per millionPage 2 of 8
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Trials 2007, 8:7 http://www.trialsjournal.com/content/8/1/7inhabitants during the last 60 years. In comparison, UK
only published about 445 and U.S.A. only about 159 pub-
lications on clinical trials per million inhabitants during
the last 60 years.
Discussion
The major findings of our ecological study are that the
number of publications on clinical trials has grown dra-
matically since 1946. The growth seems to have seized at
Number of publications on randomised controlled trials or controlled clinical trials per five-year interval since 1946 registered in CENTRAL in The Cochrane Library [4,5]Figur  1
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total number of publications, then unsurprisingly USA is
first. The ranking of countries dramatically change when
one compares the number of publications per country
with the number of publications per million inhabitants
per country during the last 60 years. Then rather small,
democratic, and wealthy countries take the lead.
Our study has a major advantage: we searched CENTRAL
in The Cochrane Library. CENTRAL represents the largest
collection of citations to publications of randomised con-
trolled trials and controlled clinical trials in the world
[4,5]. CENTRAL has identified the records on clinical tri-
als through systematic searches in MEDLINE (covering
mainly North American and European journals), EMBASE
(covering mainly European journals), Australasian Medi-
cal Index, Chinese Biomedical Literature Database, and
LILACS (Latin American Caribbean Health Sciences Liter-
ature) [4,5]. In addition, each of the 50 Cochrane Review
Groups of The Cochrane Collaboration have supplied
extensive handsearch results for CENTRAL [4,5]. There-
fore, CENTRAL includes citations to randomised control-
led and controlled clinical trials not indexed in MEDLINE,
EMBASE, or other bibliographic databases. Such citations
refer to trials published internationally in many languages
and to trials only published in conference proceedings or
other hard-to-access sources or unpublished trials [4,5].
Such publications are important because only 63% of
abstracts on randomised controlled clinical trials are later
published as full text papers [13]. Furthermore, CENTRAL
is a quickly expanding database. The groups submitting
records for inclusion in CENTRAL revise and update the
publication type code after inspection of the full text of
the publication or through communication with any of
the authors. This may lead to discrepancy of tagging of
Cochrane records when compared to records obtained
from MEDLINE or other databases. During the process of
collecting records from countries like China or Japan,
many publications on trials that state with one word to be
randomised controlled or controlled, but in fact are not,
could have entered CENTRAL. However, wrongly
included records are discovered with the production of
Cochrane systematic reviews since CENTRAL is their main
source of evidence. We were positively surprised that
about 90% of the records in CENTRAL referred to publi-
Number of publications on randomised controlled trials or controlled clinical trials published per country since 1946 regis-tered in CENTRAL in The Cochrane Library [4,5]Figur  2
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ical trials. This finding lends strengths to our findings.
Our study has a number of potential shortcomings. We
would have reached other results if we had searched other
databases or collections of databases or if all trials were
with a tag for country. Had we searched, eg, PubMed
(which includes MEDLINE plus citations not added to
MEDLINE yet) using the limits 'randomised controlled
trial' and 'human' we would have obtained only 209,909
citations, of which 38,359 referred to USA (18.3%),
11,073 to UK (5.3%), 1361 to Canada (0.6%), 1099 to
Germany (0.5%), 890 to Italy (0.4%), and 889 to The
Netherlands (0.4%) (date of search 14 April 2006).
Accordingly, our figures would have changed – in some
instances dramatically, in other instances less so. The
ranking of countries would also have changed, but appar-
ently not dramatically. Our figures should be taken with a
grain of salt. They are not representing any true number.
They should be interpreted as relative figures for compar-
ison among countries.
Second, we could only attribute a likely country of origin
to about half of the publications in CENTRAL. Inspecting
the random sample of 906 records for possible country of
origin confirmed this observation [see Additional file 1].
The difference between the two ways of searches was
minor, ie, 1.6%. The figures we have obtained are rough
estimates, more reflecting relative country contributions
than actual numbers. However, this may not represent a
major problem unless somebody can identify a non-ran-
dom process that determines which records achieve a
country tag and which do not. By additional searchers in
EMBASE and MEDLINE via WinSPIRS, version 5.0, and
Web of Science® we were able to identify a likely country
of origin for an additional 163 records on trials in CEN-
TRAL. The country distribution among these 163 records
did not differ significantly from the distribution among
the 368 records with a country identifier. This suggests
that a random process has selected which record has a
country identifier and which has not.
Third, about 10% of the random sample of 906 records
could have been included in CENTRAL in error. This per-
centage is low and lessens the concern of false positive
records on randomised controlled trials and controlled
trials when related to identifying their possible country of
origin. We have, therefore, disregarded this number in our
calculations, as we see no reason why the proportion of
Number of publications on randomised controlled trials or controlled clinical trials published per million inhabitants per coun-try since 1946 registered in CENTRAL in The Coch ane Library [4,5]Figur  3
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dependent.
Fourth, we have been unable to account for the impact of
doublets and other misclassifications. However, they are
minor and not likely to be able to change the ranking of
countries dramatically.
Fifth, CENTRAL suffers from the facts that it mainly
includes clinical trials from MEDLINE and EMBASE, and
that it does not include all clinical trials from all topic-spe-
cific or country-specific registers in the World. There are a
number of trial registers and hence trials from countries
that are not included or fully represented when one
searches CENTRAL [14-16]. This is important to remem-
ber, but it is not likely to change the ranking of countries
in the top 20 dramatically. Furthermore, a number of, e.g.,
Chinese studies turn out not to be properly randomised
[17,18]. The consequences of including registers from
such countries should accordingly be examined in depth
and require other study designs that we have presently
embarked on.
Sixth, CENTRAL is not a study-based register. Thus, we
had no chance to take into account multiple publications
of the same trial. Each randomised controlled trial is pub-
lished about twice [19]. As stated, country of origin of the
trials is not contained in the published reference, which
makes it difficult to identify the origin of more than 50%
of the published trials. Furthermore, we do not know if
the country linkage we identified represents the country
co-ordinating the trial, the country in which the partici-
pants were included, or the country in which the trial was
published (e.g., in case of abstracts and meeting proceed-
ings). Again, such misclassifications are not likely to dra-
matically change the ranking of countries.
Seventh, our study suffers from publication bias, ie, the
fact that trials are conducted, but never published [6,7].
Numerous studies show that only 30% to 80% of con-
ducted trials are published [20-23]. During the last 10
years about 25,000 publications on clinical trials are pub-
lished per year according to CENTRAL. These figures
translate into about 500 trials being launched each week
if each trial is on average published twice and only 50% of
the trials are ever published. This number of trials is dou-
ble the average number of 250 clinical trials registered per
week with ClinicalTrials.gov in USA from all over the
World [24]. This indicates that registration is not yet
100%, registrants may use other registries, or the speed of
trial launch has decreased more dramatically than our
data suggest.
The underreporting of trials is a serious ethical problem,
which undermines the confidence of people in the health-
care systems [6,7,20-23]. Furthermore, underreporting
may cause health hazards. It is, therefore, important that
the International Committee of Medical Journal Editors
[25], the World Health Organization (WHO) [26], and
others [27] endeavour at getting trial registration imple-
mented worldwide. The WHO decided in May 2006 to
urge researchers and companies to register all medical
studies that test treatments on human beings, including
the earliest studies, with patients or healthy volunteers
[28,29]. WHO's International Clinical Trials Registry Plat-
form will standardise the way information on medical
studies is made available to the public. WHO recom-
mends that 20 key details be disclosed before inclusion of
the first trial participant. These details include the country
of origin of the sponsor of the trial, of the investigators, as
well as of the participants of the trial. The fact that we were
only able to identify a likely country of origin of about
46% of the records in CENTRAL underlines the urgency
with which we have to implement WHO's call for trial reg-
istration. This call must be implemented in national laws.
The Registry Platform is not a register itself, but it provides
a set of standards for all registers that can be searched via
the Registry Platform. WHO has not only standardised
what must be reported to register a trial, but is creating a
global trial identification system that will confer a unique
reference number on every qualified trial. As indicated
above, registration has to increase substantially before full
coverage is secured.
During the last 60 years a number of countries have man-
aged to publish almost 700 publications on trials per mil-
lion inhabitants without their patient groups, their
populations, or their health-care systems to have been
overburdened by clinical trials. In fact, some of the coun-
tries with most publications on trials seem to have a more
positive attitude to clinical trial activity. If only 50% of tri-
als are published and those published are published
about twice, the publication figure translates into the con-
duct of about 700 trials per million inhabitants during the
last 60 years. This figure is a low estimate for current con-
duct of trials. Using the figure of 700 trials per million
inhabitants as a 'benchmark' for all countries, the next 60
years could bring us about 4.5 million new trials. For
medicine, this will mean a great leap forward. If just 1%
of the tested interventions are to show clinical benefit, this
could bring 7,500 new effective treatments to the market
if the count continues to be about six trials per interven-
tion [19,30].
The drop in number of publications during the last five-
year interval is likely due to a combination of factors, like
backlog in getting trial publications registered in CEN-
TRAL, slow down in the pace of clinical development, and
potential negative influence of the EU Directive 2001/20
on conduct of randomised controlled clinical trials [31].Page 6 of 8
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showing that the problem is not only European [32].
The vast majority of published controlled trials have been
conducted with insufficient sample sizes and inadequate
methodologies [33-40]. There is a growing understanding
in the world to strengthen and facilitate randomised con-
trolled trials [41-44]. The European Clinical Research
Infrastructures Network (ECRIN) has created The Interna-
tional Clinical Trials' Day each year on the day James Lind
started his famous trial: 20th of May [1,28,44]. Hereby, we
hope to increase the public understanding worldwide of
the importance of clinical research to health care. In 2006,
The International Clinical Trials' Day was marked in Brus-
sels by an ECRIN workshop and press conference sup-
ported by EU and the WHO [28].
Due to the above limitations of our study, we find that fur-
ther analyses of the number of publications on clinical tri-
als per country are warranted. Such studies could look at
the numbers based on other literature databases as well as
WHO's Registry Platform. Furthermore, studies could
analyse the clinical trial activity by taking into considera-
tion educational levels, gross domestic product, morbid-
ity, mortality, and other variables.
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